Lobbying Filing Details

Total Spending

$50,000

Activities

1

Lobbyists

3

Gov't Entities

4

Filing Information
Filing UUID:
49fbff0d-5cef-4ee3-9748-3097888759af
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 05, 2026 at 10:16 AM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
LMH STRATEGIC SOLUTIONS
Washington, District of Columbia
Client
PTC THERAPEUTICS, INC.

Biopharmaceutical company.

New Jersey, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Issues related to access to rare disease therapies, diagnosis and testing. Issues related to FDA modernization and rare disease drug development. Issues related to the Accelerated Approval Program. Issues related to Public Law No. 117-169 - The Inflation Reduction Act of 2022. Issues related to alternative funding programs. Issues related to the Rare Pediatric Disease Priority Review Voucher program, including H.R.1262/S.932 - Give Kids a Chance Act of 2025.

Lobbyists (3)
  • ALANNA TEMME
  • SONIA GOH
  • SOPHIE KHANAHMADI
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved October 30, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.